Maravai Total Debt To Capitalization from 2010 to 2024
MRVI Stock | USD 10.85 0.07 0.65% |
Total Debt To Capitalization | First Reported 2010-12-31 | Previous Quarter 0.56053223 | Current Value 0.74 | Quarterly Volatility 0.07935747 |
Check Maravai Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maravai main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 33.9 M or Selling General Administrative of 103.3 M, as well as many exotic indicators such as Price To Sales Ratio of 2.84, Dividend Yield of 0.0 or PTB Ratio of 1.97. Maravai financial statements analysis is a perfect complement when working with Maravai Lifesciences Valuation or Volatility modules.
Maravai | Total Debt To Capitalization |
Latest Maravai Lifesciences' Total Debt To Capitalization Growth Pattern
Below is the plot of the Total Debt To Capitalization of Maravai Lifesciences HoldingsInc over the last few years. It is Maravai Lifesciences' Total Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Maravai Lifesciences' overall financial position and show how it may be relating to other accounts over time.
Total Debt To Capitalization | 10 Years Trend |
|
Total Debt To Capitalization |
Timeline |
Maravai Total Debt To Capitalization Regression Statistics
Arithmetic Mean | 0.69 | |
Geometric Mean | 0.69 | |
Coefficient Of Variation | 11.48 | |
Mean Deviation | 0.05 | |
Median | 0.70 | |
Standard Deviation | 0.08 | |
Sample Variance | 0.01 | |
Range | 0.352 | |
R-Value | (0.25) | |
Mean Square Error | 0.01 | |
R-Squared | 0.06 | |
Significance | 0.38 | |
Slope | (0) | |
Total Sum of Squares | 0.09 |
Maravai Total Debt To Capitalization History
About Maravai Lifesciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Maravai Lifesciences income statement, its balance sheet, and the statement of cash flows. Maravai Lifesciences investors use historical funamental indicators, such as Maravai Lifesciences's Total Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although Maravai Lifesciences investors may use each financial statement separately, they are all related. The changes in Maravai Lifesciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Maravai Lifesciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Maravai Lifesciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Maravai Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Debt To Capitalization | 0.56 | 0.74 |
Currently Active Assets on Macroaxis
OEPIX | Oil Equipment Services | |
MMM | 3M Company | |
SLV | iShares Silver Trust | |
AZPN | Aspen Technology | |
ORCL | Oracle |
Check out the analysis of Maravai Lifesciences Correlation against competitors. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Maravai Stock analysis
When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Maravai Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (0.99) | Revenue Per Share 2.075 | Quarterly Revenue Growth (0.19) | Return On Assets (0.02) |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.